KRAS mutation testing in human cancers: The pathologist's role in the era of personalized medicine
{{output}}
A number of studies have shown that although antiepidermal growth factor receptor (EGFR) monoclonal antibodies are effective treatments for metastatic colorectal cancer (mCRC), only patients with wild-type KRAS tumors derive clinical benefit from these therapi... ...
